3-MeO-PCE: Difference between revisions
>Unity No edit summary |
>Unity No edit summary |
||
Line 135: | Line 135: | ||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
*[[Responsible chemical]] | |||
*[[3-MeO-PCP]] | *[[3-MeO-PCP]] | ||
*[[PCP]] | *[[PCP]] | ||
Line 144: | Line 145: | ||
*[http://www.bluelight.org/vb/threads/532702-The-Big-amp-Dandy-3-MeO-PCE-Thread 3-MeO-PCE (Bluelight)] | *[http://www.bluelight.org/vb/threads/532702-The-Big-amp-Dandy-3-MeO-PCE-Thread 3-MeO-PCE (Bluelight)] | ||
*[http://drugs.tripsit.me/3-meo-pcp 3-MeO-PCE (Tripsit)] | *[http://drugs.tripsit.me/3-meo-pcp 3-MeO-PCE (Tripsit)] | ||
*[https://web.archive.org/web/20170111011440*/https://www.vice.com/en_us/article/interview-with-ketamine-chemist-704-v18n2 Interview with a Ketamine Chemist (VICE)] | |||
==Literature== | |||
* Morris, H., & Wallach, J. (2014). From PCP to MXE: A comprehensive review of the non-medical use of dissociative drugs. Drug Testing and Analysis, 6(7–8), 614–632. https://doi.org/10.1002/dta.1620 | |||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category:Psychoactive substance]] | [[Category:Psychoactive substance]] | ||
[[Category:Research chemical]] | |||
[[Category:Arylcyclohexylamine]] | [[Category:Arylcyclohexylamine]] | ||
[[Category:Piperidine]] | [[Category:Piperidine]] | ||
[[Category:Dissociative]] | [[Category:Dissociative]] | ||
{{#set:Featured=true}} | {{#set:Featured=true}} |